Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2024-07-17 13:28:29
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES (OR ANY OTHER
JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL). THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.
Date on which the terms and conditions of the preferential rights issue were
announced: On or about 17th of July 2024
Last day including right: 31st of July 2024
Ex-date: 1st of August 2024
Record Date: 2nd of August 2024
Date of approval: 31st of July 2024
Number of new shares: Minimum 1.125.007.508 and maximum 1.237.508.259 new shares
Subscription price: NOK 0,02
Will the rights be listed - yes/no: Yes
This information is published in accordance with the requirements of the
Continuing Obligations.
Reference is made to the notice of the extraordinary general meeting in Softox
Solutions AS announced through a stock exchange notification on 17th of July
2024 for further information regarding the rights issue.
Freely tradable subscription rights will be applied for listing on the Euronext
Growth and will be tradable from the commencement of the subscription period and
until on or about 21st of August 2024, two days prior to the expiry of the
subscription period.